The siblings we describe here provide strong support for the effectiveness and importance of folinic acid treatment initiation at a very early age in patients with pathogenic variants in FOLR1 and neurodegeneration due to cerebral folate deficiency. The gene discussed is FOLR1; the disease is folate deficiency.